1. Home
  2. NVRI vs RAPP Comparison

NVRI vs RAPP Comparison

Compare NVRI & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enviri Corporation

NVRI

Enviri Corporation

HOLD

Current Price

$19.63

Market Cap

1.6B

Sector

Miscellaneous

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$37.77

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVRI
RAPP
Founded
1853
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Sector
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
1994
2024

Fundamental Metrics

Financial Performance
Metric
NVRI
RAPP
Price
$19.63
$37.77
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$48.50
AVG Volume (30 Days)
782.9K
356.3K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
24.34
EPS
N/A
N/A
Revenue
$2,240,358,000.00
N/A
Revenue This Year
$3.87
N/A
Revenue Next Year
$3.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.35
$7.73
52 Week High
$19.99
$42.27

Technical Indicators

Market Signals
Indicator
NVRI
RAPP
Relative Strength Index (RSI) 56.06 57.35
Support Level $18.90 $25.48
Resistance Level $19.71 $41.59
Average True Range (ATR) 0.53 2.37
MACD -0.00 0.02
Stochastic Oscillator 81.47 62.93

Price Performance

Historical Comparison
NVRI
RAPP

About NVRI Enviri Corporation

Enviri Corp is a market-leading, provider of environmental solutions for industrial and specialty waste streams, and equipment and technology for the rail sector. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company gains its revenue from Harsco Environmental segment. Geographically company operates in USA and International Countries, with majority revenue from USA.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: